Cancer News: Overview of KEYNOTE-671 & NADIM II Trials by Dr. Lei Deng

Dr. Lei Deng, of the University of Washington and Fred Hutch, discusses the KEYNOTE-671 & NADIM II trials and the implications for the treatment of non small cell lung cancer.